NIH provides Corgenix $2.9M grant for Ebola test kit

BROOMFIELD – Corgenix Medical Corp. has been awarded a three-year $2.9 million grant from the National Institutes of Health to advance the development of an Ebola rapid diagnostic test kit.

Corgenix is a member of the Viral Hemorrhagic Fever Consortium, a collaboration of academic and industry members headed by Tulane University. The consortium seeks to better understand, treat and prevent viral hemorrhagic diseases such as Ebola and Lassa fever, a similar but less deadly disease.

The latest grant from the NIH is a continuation of a previous two-year grant to develop special proteins for use in testing for Ebola. The diagnostic test…